363 related articles for article (PubMed ID: 26291965)
21. The polymorphic pseudokinase ROP5 controls virulence in Toxoplasma gondii by regulating the active kinase ROP18.
Behnke MS; Fentress SJ; Mashayekhi M; Li LX; Taylor GA; Sibley LD
PLoS Pathog; 2012; 8(11):e1002992. PubMed ID: 23144612
[TBL] [Abstract][Full Text] [Related]
22. Molecular and biological analysis revealed genetic diversity and high virulence strain of Toxoplasma gondii in Japan.
Fukumoto J; Yamano A; Matsuzaki M; Kyan H; Masatani T; Matsuo T; Matsui T; Murakami M; Takashima Y; Matsubara R; Tahara M; Sakura T; Takeuchi F; Nagamune K
PLoS One; 2020; 15(2):e0227749. PubMed ID: 32012177
[TBL] [Abstract][Full Text] [Related]
23. Genetic Mapping of Pathogenesis Determinants in Toxoplasma gondii.
Behnke MS; Dubey JP; Sibley LD
Annu Rev Microbiol; 2016 Sep; 70():63-81. PubMed ID: 27359216
[TBL] [Abstract][Full Text] [Related]
24.
Hashizaki E; Sasai M; Okuzaki D; Nishi T; Kobayashi T; Iwanaga S; Yamamoto M
mBio; 2023 Feb; 14(1):e0325622. PubMed ID: 36715543
[TBL] [Abstract][Full Text] [Related]
25. A polymorphism in a DNA polymerase alpha gene intron differentiates between murine virulent and avirulent strains of Toxoplasma gondii.
Biñas M; Johnson AM
Int J Parasitol; 1998 Jul; 28(7):1033-40. PubMed ID: 9724874
[TBL] [Abstract][Full Text] [Related]
26. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice.
Zheng B; Lu S; Tong Q; Kong Q; Lou D
Vaccine; 2013 Sep; 31(41):4578-84. PubMed ID: 23928460
[TBL] [Abstract][Full Text] [Related]
27. [Toxoplasma gondii--known and unknown parasite].
Długońska H
Wiad Parazytol; 2008; 54(3):199-204. PubMed ID: 19055060
[TBL] [Abstract][Full Text] [Related]
28. Effect of deletion of gra17 and gra23 genes on the growth, virulence, and immunogenicity of type II Toxoplasma gondii.
Li TT; Wang JL; Liang QL; Sun LX; Zhang HS; Zhang ZW; Zhu XQ; Elsheikha HM
Parasitol Res; 2020 Sep; 119(9):2907-2916. PubMed ID: 32686022
[TBL] [Abstract][Full Text] [Related]
29. Atypical virulence in a type III Toxoplasma gondii strain isolated in Japan.
Taniguchi Y; Appiah-Kwarteng C; Murakami M; Fukumoto J; Nagamune K; Matsuo T; Masatani T; Kanuka H; Hoshina T; Kitoh K; Takashima Y
Parasitol Int; 2018 Oct; 67(5):587-592. PubMed ID: 29775826
[TBL] [Abstract][Full Text] [Related]
30. ROP18 is a key factor responsible for virulence difference between Toxoplasma gondii and Neospora caninum.
Lei T; Wang H; Liu J; Nan H; Liu Q
PLoS One; 2014; 9(6):e99744. PubMed ID: 24927100
[TBL] [Abstract][Full Text] [Related]
31. Molecular mechanism for the control of virulent Toxoplasma gondii infections in wild-derived mice.
Murillo-León M; Müller UB; Zimmermann I; Singh S; Widdershooven P; Campos C; Alvarez C; Könen-Waisman S; Lukes N; Ruzsics Z; Howard JC; Schwemmle M; Steinfeldt T
Nat Commun; 2019 Mar; 10(1):1233. PubMed ID: 30874554
[TBL] [Abstract][Full Text] [Related]
32. TgROP18 targets IL20RB for host-defense-related-STAT3 activation during Toxoplasma gondii infection.
Kong L; Jiang D; He C; Xia J; Wei H; Zhou L; Peng H
Parasit Vectors; 2020 Aug; 13(1):400. PubMed ID: 32767999
[TBL] [Abstract][Full Text] [Related]
33. [Research Advances on Toxoplasma gondii Virulence Mediating Factors].
Xia J; Peng HJ
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2015 Aug; 33(4):297-300. PubMed ID: 26672224
[TBL] [Abstract][Full Text] [Related]
34. Toxoplasma gondii: Cytokine responses in mice reinfected with atypical strains.
Costa JGL; Pinto LV; Baraviera RCA; Geiger SM; Silva Araújo MS; Martins-Filho OA; Vitor RWA
Exp Parasitol; 2020 Nov; 218():108006. PubMed ID: 32991867
[TBL] [Abstract][Full Text] [Related]
35. Toxoplasma gondii GRA60 is an effector protein that modulates host cell autonomous immunity and contributes to virulence.
Nyonda MA; Hammoudi PM; Ye S; Maire J; Marq JB; Yamamoto M; Soldati-Favre D
Cell Microbiol; 2021 Feb; 23(2):e13278. PubMed ID: 33040458
[TBL] [Abstract][Full Text] [Related]
36. The arginine-rich N-terminal domain of ROP18 is necessary for vacuole targeting and virulence of Toxoplasma gondii.
Fentress SJ; Steinfeldt T; Howard JC; Sibley LD
Cell Microbiol; 2012 Dec; 14(12):1921-33. PubMed ID: 22906355
[TBL] [Abstract][Full Text] [Related]
37. Genetic characterization of Toxoplasma gondii from human and chicken isolates from Argentina.
Bernstein M; Rudzinski M; Schneider V; Messina M; Gos ML; Helman E; Dellarupe A; Unzaga JM; Venturini MC; Moré G; Pardini L
Parasitol Res; 2024 Feb; 123(2):129. PubMed ID: 38332310
[TBL] [Abstract][Full Text] [Related]
38. Functional Analysis of the Role of Toxoplasma gondii Nucleoside Triphosphate Hydrolases I and II in Acute Mouse Virulence and Immune Suppression.
Olias P; Sibley LD
Infect Immun; 2016 Jul; 84(7):1994-2001. PubMed ID: 27091930
[TBL] [Abstract][Full Text] [Related]
39. ATF6beta is a host cellular target of the Toxoplasma gondii virulence factor ROP18.
Yamamoto M; Ma JS; Mueller C; Kamiyama N; Saiga H; Kubo E; Kimura T; Okamoto T; Okuyama M; Kayama H; Nagamune K; Takashima S; Matsuura Y; Soldati-Favre D; Takeda K
J Exp Med; 2011 Jul; 208(7):1533-46. PubMed ID: 21670204
[TBL] [Abstract][Full Text] [Related]
40. Recent transcontinental sweep of Toxoplasma gondii driven by a single monomorphic chromosome.
Khan A; Fux B; Su C; Dubey JP; Darde ML; Ajioka JW; Rosenthal BM; Sibley LD
Proc Natl Acad Sci U S A; 2007 Sep; 104(37):14872-7. PubMed ID: 17804804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
